GENEME MOLECULAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
GENEME MOLECULAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.
Incorporation date
24/11/2021Share capital
5,000.00 PLNPrimary activity
Other human health activities notelsewhere classified (86.90.E - PKD 2007)Representatives
0Representatives rights
W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO DO REPREZENTOWANIA SPÓŁKI, SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI UPRAWNIONYCH JEST DWÓCH CZŁONKÓW ZARZĄDU ŁĄCZNIE.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-24,128Net Profit (zł)
-24,128Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 48,800 |
| -91,864 |
| -91,864 |
| -0.35 |
| 0.92 |
| -188.25 |
| -86,864 |
| 214,318 |
| 69,895 |
| 0 |
| 2023 |
|---|
| 345,989 |
| 107,219 |
| 102,575 |
| 0.26 |
| 1.26 |
| 29.65 |
| 15,712 |
| 346,802 |
| 74,986 |
| 0 |
| 2024 |
|---|
| 40,000 |
| -23,908 |
| -24,128 |
| 1.79 |
| 1.20 |
| -60.32 |
| -8,416 |
| 365,283 |
| 80,132 |
| 0 |
| 2024 |
|---|
| 40,000 |
| -23,908 |
| -24,128 |
| 1.79 |
| 1.20 |
| -60.32 |
| -8,416 |
| 365,283 |
| 80,132 |
| 0 |
Turnover (zł)
2024
Turnover (zł)
40,000 zł
-88 % *
Profit before tax (zł)
-23,908 zł-122 % *
Net Profit (zł)
-24,128 zł-124 % *
Working capital requirement (%)
1.79 
588.46 % *
Liquidity ratio
1.20 -4.76 % *
Net profitability (%)
-60.32 %-303.44 % *
Equity (zł)
-8,416 zł-154 % *
Current liabilities (zł)
365,283 zł
5 % *
Non current liabilities (zł)
80,132 zł7 % *
Non-current Assets (zł)
0 zł
- *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
GENEME MOLECULAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
15/07/2025 | OD 01.01.2024 DO 31.12.2024 |
18/07/2024 | OD 11.10.2021 DO 31.12.2022 |
16/07/2024 | OD 01.01.2023 DO 31.12.2023 |